Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Heron Therapeutics (HRTX) Other Working Capital Changes: 2010-2025

Historic Other Working Capital Changes for Heron Therapeutics (HRTX) over the last 11 years, with Sep 2025 value amounting to $5.2 million.

  • Heron Therapeutics' Other Working Capital Changes rose 36.81% to $5.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.7 million, marking a year-over-year increase of 1059.50%. This contributed to the annual value of $9.9 million for FY2024, which is 164.35% up from last year.
  • As of Q3 2025, Heron Therapeutics' Other Working Capital Changes stood at $5.2 million, which was up 156.42% from -$9.3 million recorded in Q2 2025.
  • Over the past 5 years, Heron Therapeutics' Other Working Capital Changes peaked at $8.6 million during Q1 2025, and registered a low of -$9.5 million during Q2 2023.
  • In the last 3 years, Heron Therapeutics' Other Working Capital Changes had a median value of -$172,000 in 2023 and averaged -$86,273.
  • Over the last 5 years, Heron Therapeutics' Other Working Capital Changes had its largest YoY gain of 3,775.68% in 2025, and its largest YoY loss of 3,118.69% in 2025.
  • Over the past 5 years, Heron Therapeutics' Other Working Capital Changes (Quarterly) stood at $2.7 million in 2021, then spiked by 75.19% to $4.7 million in 2022, then crashed by 203.58% to -$4.9 million in 2023, then surged by 226.06% to $6.2 million in 2024, then spiked by 36.81% to $5.2 million in 2025.
  • Its Other Working Capital Changes was $5.2 million in Q3 2025, compared to -$9.3 million in Q2 2025 and $8.6 million in Q1 2025.